Subscribe to Search results

There was little discussion of issues relating to hepatitis at the haemophilia reference centre directors'

Published on:

Dr Craske gave a presentation on the work of the Hepatitis Working Party at the UKHCDO annual meeting

Published on:

The Hepatitis Working Party agreed more information was needed on the risk to patients of developing chronic NANBH, by prospectively following patients first exposed to concentrate or other products, such as people with mild haemophilia undergoing non-emergency surgery.

Published on:

Dr Peter Jones became director of the Newcastle Haemophilia Centre.

Published on:

Dr Peter Jones believed the major part of his responsibility was "a regional commitment to the care of children and adults with haemophilia".

Published on:

There were 43 patients on home therapy, with a mean Factor 8 usage of 18,796 units per patient per year at Newcastle Haemophilia Centre.

Published on:

Prophylaxis was a feature of treatment policy at Newcastle Haemophilia Centre.

Published on:

Dr Peter Jones had no doubt that haemophiliacs exposed to multi donor concentrates were infected with non-A non-B hepatitis and that a substantial number would go on to develop chronic liver disease.

Published on:

Dr Peter Jones suggested AIDS in haemophilia patients was brought to the attention of haemophilia centre directors by Professor Bloom at a meeting of the Haemophilia Reference Centre Directors.

Published on:

Dr Peter Jones was joined by Dr Peter Hamilton as co-director of the Newcastle Haemophilia Centre.

Published on:

Dr Jones' "Guidelines for the Organisation of a Haemophilia Centre" recorded that "within our geographical region, which has a population of 3.3 million, the home therapy programme is run from the Newcastle Centre and all patients are followed up there by the core team."

Published on:

In a letter from Dr Jones to Dr Sackwood, it was noted that 23 patients were on home therapy in the Newcastle area.

Published on:

Dr Jones suggested in his statement to the Inquiry, that cryoprecipitate was the treatment of choice until 1973, "when sufficient Factor VIII became available".

Published on:

Dr Jones stated that the introduction of concentrates allowed the development of home therapy and eventually prophylactic treatment.

Published on:

Dr Jones suggested that the Newcastle centre's policy was to encourage both home and prophylaxis treatment.

Published on:

Dr Jones told his patients that a substantial proportion of those infected with NANBH would develop liver disease

Published on:

Dr Jones noted that cryoprecipitate was the treatment of choice for haemophiliacs, but when not available FFP would be used.

Published on:

Dr Jones championed the use of cryoprecipitate in haemophiliacs as early as 1972, as per his article "Answering the needs of haemophilic children and their families Community Medicine"

Published on:

It was noted in a report on the optimum use of Factor VIII preparations that at the Newcastle Haemophilia Centre cryoprecipitate would be used to treat bleeds in most circumstances and it was also used for surgery and dental extraction, whilst Hemofil was used for home therapy and for severe bleeds.

Published on:

Dr Jones stated in a publication 'AIDS and the Blood' that it was best practice to treat children under 4 with cryoprecipitate.

Published on: